調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

世界のHCS（High Content Screening：バイオ産業）市場動向と予測（～2018）

◆タイトル：High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
◆商品コード：BT 2227
◆調査・発行会社：MarketsandMarkets
◆発行日：2014年2月
◆ページ数：151
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User（～5名）USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate licence（社内共有可） USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"世界のHCS（High Content Screening：バイオ産業）市場動向と予測（～2018）"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の機会と課題、市場の動態、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

The global high content screening market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery. The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.
In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.

The global high content screening market is competitive and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the high content screening market. The report analyzes the high content screening market by application across geographies

Product Development/Innovation: Detailed insights on research and development activities and new product launches in the high content screening market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the high content screening market by product across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market

Competitive Assessment: In-depth assessment of market shares, strategies, products and services, and distribution networks in the high content screening market

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown and Data Triangulation
1.6.3 Market Share
1.6.4 Key Data Points From Primary Sources
1.6.5 Key Data Points From Secondary Sources

2 Executive Summary (Page No. – 25)

3 Market Overview (Page No. – 29)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
3.3.1.2 Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
3.3.1.3 Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
3.3.2 Restraints
3.3.2.1 High Cost of High Content Screening Systems May Hinder the Market Growth
3.3.3 Opportunities
3.3.3.1 Contract Research Organizations Have Significant Opportunities To Provide HCS Services
3.3.3.2 Adoption of High Content Screening For Primary Screening
3.3.3.3 Application of High Content Screening in Personalized Medicine
3.3.3.4 Collaborations To Increase Innovation in the HCS Market
3.3.4 Challenges
3.3.4.1 Shortage of Knowledgeable and Skilled Professionals For High Content Screening
3.4 Market Share Analysis

4 By Product Type (Page No. – 41)
4.1 Introduction
4.2 Instruments
4.2.1 Cell Imaging and Analysis Systems
4.2.2 Flow Cytometers
4.3 Consumables
4.3.1 Reagents & Assay Kits
4.3.2 Microplates
4.3.3 Other Consumables
4.4 Software
4.5 Services

5 By Application (Page No. – 60)
5.1 Introduction
5.1.1 Target Identification and Validation
5.1.2 Primary Screening and Secondary Screening
5.1.3 Toxicity Studies
5.1.4 Compound Profiling
5.1.5 Other Applications

6 By End Users (Page No. – 71)
6.1 Pharmaceutical and Biotechnology Companies
6.2 Academia and Government Institutes
6.3 Contract Research Organizations (CRO)

7 Geographic Analysis (Page No. – 80)
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia
7.5 ROW

8 Competitive Landscape (Page No. – 103)
8.1 Introduction
8.2 New Product Launch
8.3 Expansions
8.4 Agreements, Collabarations, Partnerships
8.5 Acquisitions

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 114)
9.1 Becton, Dickinson and Company
9.2 Cell Signaling Technology, Inc.
9.3 Danaher Corporation
9.4 Ge Healthcare (Subsidiary of General Electric Company)
9.5 Genedata Ag
9.6 Merck Kgaa
9.7 Perkinelmer, Inc.
9.8 thermo Fisher Scientific, Inc.
9.9 Thorlabs, Inc.
9.10 Yokogawa Electric Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (50 Tables)

Table 1 Global Market, By Product Type, 2011-2018 ($Million)
Table 2 HCS Products Market, By Geography, 2011-2018 ($Million)
Table 3 The Global High Content Screening Instruments Market, By Type, 2011-2018 ($Million)
Table 4 HCS Instruments Market, By Geography, 2011-2018 ($Million)
Table 5 Cell Imaging and Analysis HCS Systems Market, By Geography, 2011-2018 ($Million)
Table 6 HCS Flow Cytometers Market, By Geography, 2011-2018 ($Million)
Table 7 Global HCS Consumables Market, By Type, 2011-2018 ($Million)
Table 8 HCS Consumables Market, By Geography, 2011-2018 ($Million)
Table 9 HCS Reagents and Assay Kits Market, By Geography, 2011-2018 ($Million)
Table 10 HCS Microplates Market, By Geography, 2011-2018 ($Million)
Table 11 HCS Other Consumables Market, By Geography, 2011-2018 ($Million)
Table 12 HCS Software Market, By Geography, 2011-2018 ($Million)
Table 13 HCS Services Market, By Geography, 2011-2018 ($Million)
Table 14 Global HCS Applications Market, By Type, 2011-2018 ($Million)
Table 15 HCS Applications Market, By Geography, 2011-2018 ($Million)
Table 16 HCS Target Identification and Validation Market, By Geography, 2011-2018 ($Million)
Table 17 HCS Primary and Secondary Screening Market, By Geography, 2011-2018 ($Million)
Table 18 HCS Toxicity Studies Market, By Geography, 2011-2018 ($Million)
Table 19 HCS Compound Profiling Market, By Geography, 2011-2018 ($Million)
Table 20 HCS Other Applications Market, By Geography, 2011-2018 ($Million)
Table 21 Global Market, By End User, 2011-2018 ($Million)
Table 22 HCS End Users Market, By Geography ($Million)
Table 23 Pharmaceutical and Biotechnology Companies HCS Market, By Geography, 2011-2018 ($Million)
Table 24 Academia and Government Institutes HCS Market, By Geography, 2011-2018 ($Million)
Table 25 Contract Research Organization HCS Market, By Geography, 2011-2018 ($Million)
Table 26 HCS Product Market, By Geography, 2011-2018 ($Million)
Table 27 North America: Market, By Product Type, 2011-2018 ($Million)
Table 28 North America: HCS Instruments Market, By Type, 2011-2018 ($Million)
Table 29 North America: HCS Consumables Market, By Type, 2011-2018 ($Million)
Table 30 North America: Market, By Application Type, 2011-2018 ($Millions)
Table 31 North America: Market, By End User, 2011-2018 ($Million)
Table 32 Europe: Market, By Product Type, 2011-2018 ($Million)
Table 33 Europe: HCS Instruments Market, By Type, 2011-2018 ($Million)
Table 34 Europe: HCS Consumables Market, By Type, 2011-2018 ($Million)
Table 35 Europe: Market, By Application Type, 2011-2018 ($Million)
Table 36 Europe: Market, By End User, 2011-2018 ($Million)
Table 37 Asia: Market, By Product Type, 2011-2018 ($Million)
Table 38 Asia: HCS Instruments Market, By Type, 2011-2018 ($Million)
Table 39 Asia: HCS Consumables Market, By Type, 2011-2018 ($Million)
Table 40 Asia: Market, By Application, 2011-2018 ($Million)
Table 41 Asia: Market, By End User, 2011-2018 ($Million)
Table 42 ROW: Market, By Product Type, 2011-2018 ($Million)
Table 43 ROW: HCS Instruments Market, By Type, 2011-2018 ($Million)
Table 44 ROW: HCS Consumables Market, By Type, 2011-2018 ($Million)
Table 45 ROW: Market, By Application, 2011-2018 ($Million)
Table 46 ROW: Market, By End User, 2011-2018 ($Million)
Table 47 New Product Launch, 2011-2013
Table 48 Expansions, 2011-2013
Table 49 Agreements, Partnerships, Collabarations, 2011-2013
Table 50 Acquisitions, 2011-2013

List of Figures (10 Figures)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology
Figure 3 Market Crackdown & Data Triangulation Methodology For the HCS Market
Figure 4 Global Market, By Product, 2013-2018 ($Million)
Figure 5 HCS Market, By Geography, 2013-2018 ($Million)
Figure 6 Market Segmentation
Figure 7 Market Dynamics
Figure 8 Global HCS Instruments Market Share, By Key Players, 2013
Figure 9 HCS Products Market, By Geography, 2013
Figure 10 Key Growth Strategies, HCS Market, 2011-2013

★調査レポート[世界のHCS（High Content Screening：バイオ産業）市場動向と予測（～2018）] ( High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018 / BT 2227) 販売に関する免責事項
[世界のHCS（High Content Screening：バイオ産業）市場動向と予測（～2018）] ( High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018 / BT 2227) についてEメールでお問い合わせ
◆関連調査資料◆
  • ハイコンテントスクリーニング（HCS）の世界市場予測（～2022年）：細胞画像・分析システム、フローサイトメトリー、ソフトウェア、サービス
    MAM-BT2227 / MarketsandMarkets / 2017年4月13日 / 当調査レポートでは、ハイコンテントスクリーニング（HCS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品別分析、用途別分析、需要先別分析、地域別分析、ハイコンテントスクリーニング（HCS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major lifesciences market players, and government support are some of the factors attributed to the large share of North America in the HCS market. The major players in the market are GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland),...
  • ハイスループットスクリーニング（HTS）の世界市場予測（～2023年）：細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス
    BT2220 / MarketsandMarkets / 2018年4月24日 / 当調査レポートでは、ハイスループットスクリーニング（HTS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術（細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス）別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニング（HTS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global high-throughput screening (HTS) market is projected to reach USD 21.69 Billion by 2023 from USD 14.87 Billion in 2018, at a CAGR of 7.8%. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments. The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS...
  • 薬物スクリーニング検査の世界市場予測（～2022年）：免疫測定アナライザー、クロマトグラフィー、飲酒検知器、迅速検査デバイス、アッセイキット
    MD-3239 / MarketsandMarkets / 2018年1月15日 / MarketsandMarketsが発行した当調査レポートでは、薬物スクリーニング検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、サービス別分析、サンプル種類別分析、需要先別分析、薬物スクリーニング検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global drug screening market projected to grow at a CAGR of 10.2% during the forecast period”The drug screening market is expected to reach USD 8.63 billion million by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban...
  • セルラー集団検診（健診）の世界市場予測（～2022年）
    MAM-BT5413 / MarketsandMarkets / 2017年7月14日 / 当調査レポートでは、セルラー集団検診（健診）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、サンプル別分析、健診場所別分析、地域別分析、セルラー集団検診（健診）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cellular health screening market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period. A number of factors such as increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are driving the demand for global cellular health screening. On the...
  • 細胞培養の世界市場予測（～2023年）：消耗品、装置、用途、地域別分析
    MAM-BT-2561 / MarketsandMarkets / 2018年4月13日 / MarketsandMarketsが発行した当調査レポートでは、細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、消耗品別分析、装置別分析、用途別分析、地域別分析、細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell culture market is expected to reach USD 26.28 Billion by 2023 from USD 15.32 Billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. This report segments the global market into product, application, end user, and region. Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share...
  • 細胞アッセイの世界市場予測（～2022年）：試薬、アッセイキット、マイクロプレート、細胞株、サービス
    MAM-BT2486 / MarketsandMarkets / 2017年7月6日 / 当調査レポートでは、細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4%. A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market. The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global...
  • 細胞解離の世界市場予測（～2023年）：酵素系（コラゲナーゼ、トリプシン、DNase、エラスターゼ）、非酵素系
    MAM-BT-6129 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、細胞解離の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、組織別分析、需要先別分析、細胞解離の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%. Market growth is primarily driven by the rising R&D investments in the life sciences industry, increasing research on chronic diseases and rising government funding for cancer research. The global cell dissociation market is segmented by product, tissue, type, end user, and region. By product, the cell dissociation market segmented into enzymatic dissociation products, non-enzymatic dissociation products and instruments & accessories. The enzymatic dissociation products segment estimated to account for the largest market of the global...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆